000288993 001__ 288993
000288993 005__ 20250514132959.0
000288993 0247_ $$2doi$$a10.1002/cac2.12526
000288993 0247_ $$2pmid$$apmid:38487965
000288993 0247_ $$2ISSN$$a1000-467X
000288993 0247_ $$2ISSN$$a1944-446X
000288993 0247_ $$2ISSN$$a2523-3548
000288993 0247_ $$2altmetric$$aaltmetric:160777172
000288993 037__ $$aDKFZ-2024-00540
000288993 041__ $$aEnglish
000288993 082__ $$a610
000288993 1001_ $$00000-0001-8504-1618$$aJansana, Anna$$b0
000288993 245__ $$aImpact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study.
000288993 260__ $$aHoboken, NJ$$bWiley$$c2024
000288993 3367_ $$2DRIVER$$aarticle
000288993 3367_ $$2DataCite$$aOutput Types/Journal article
000288993 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1716466452_27470
000288993 3367_ $$2BibTeX$$aARTICLE
000288993 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000288993 3367_ $$00$$2EndNote$$aJournal Article
000288993 500__ $$a2024 May;44(5):593-597
000288993 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000288993 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000288993 7001_ $$aAuguste, Aviane$$b1
000288993 7001_ $$aKvaskoff, Marina$$b2
000288993 7001_ $$aFournier, Agnès$$b3
000288993 7001_ $$aFontvieille, Emma$$b4
000288993 7001_ $$aPeruchet-Noray, Laia$$b5
000288993 7001_ $$aBiessy, Carine$$b6
000288993 7001_ $$aCordova, Reynalda$$b7
000288993 7001_ $$aNielsen Petersen, Kristina Elin$$b8
000288993 7001_ $$aTjønneland, Anne$$b9
000288993 7001_ $$0P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aKatzke, Verena$$b10$$udkfz
000288993 7001_ $$0P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aKaaks, Rudolf$$b11$$udkfz
000288993 7001_ $$aRicceri, Fulvio$$b12
000288993 7001_ $$aPanico, Salvatore$$b13
000288993 7001_ $$aContiero, Paolo$$b14
000288993 7001_ $$aSánchez, Maria-Jose$$b15
000288993 7001_ $$aCastilla, Jesus$$b16
000288993 7001_ $$aCrous-Bou, Marta$$b17
000288993 7001_ $$aHeath, Alicia$$b18
000288993 7001_ $$aAglago, Elom Kouassivi$$b19
000288993 7001_ $$aWeiderpass, Elisabete$$b20
000288993 7001_ $$aGunter, Marc James$$b21
000288993 7001_ $$aFerrari, Pietro$$b22
000288993 7001_ $$aRiboli, Elio$$b23
000288993 7001_ $$aViallon, Vivian$$b24
000288993 7001_ $$aFreisling, Heinz$$b25
000288993 773__ $$0PERI:(DE-600)2922913-3$$a10.1002/cac2.12526$$gp. cac2.12526$$n5$$p593-597$$tCancer communications$$v44$$x1000-467X$$y2024
000288993 8564_ $$uhttps://inrepo02.dkfz.de/record/288993/files/Cancer%20Communications%20-%202024%20-%20Jansana%20-%20Impact%20of%20pre%E2%80%90existing%20cardiometabolic%20diseases%20on%20metastatic%20cancer%20stage%20at.pdf
000288993 8564_ $$uhttps://inrepo02.dkfz.de/record/288993/files/Cancer%20Communications%20-%202024%20-%20Jansana%20-%20Impact%20of%20pre%E2%80%90existing%20cardiometabolic%20diseases%20on%20metastatic%20cancer%20stage%20at.pdf?subformat=pdfa$$xpdfa
000288993 909CO $$ooai:inrepo02.dkfz.de:288993$$pVDB
000288993 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000288993 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000288993 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000288993 9141_ $$y2024
000288993 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-27
000288993 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-27
000288993 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-05-02T09:05:11Z
000288993 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-05-02T09:05:11Z
000288993 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-05-02T09:05:11Z
000288993 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2023-05-02T09:05:11Z
000288993 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER COMMUN : 2022$$d2023-10-27
000288993 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-27
000288993 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-27
000288993 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-27
000288993 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-27
000288993 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-27
000288993 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-27
000288993 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-27
000288993 915__ $$0StatID:(DE-HGF)9915$$2StatID$$aIF >= 15$$bCANCER COMMUN : 2022$$d2023-10-27
000288993 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-27
000288993 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-27
000288993 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000288993 980__ $$ajournal
000288993 980__ $$aVDB
000288993 980__ $$aI:(DE-He78)C020-20160331
000288993 980__ $$aUNRESTRICTED